U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. Drug Safety and Availability
  4. Food and Drug Administration Overdose Prevention Framework
  5. Encouraging Harm Reduction
  1. Food and Drug Administration Overdose Prevention Framework

Encouraging Harm Reduction

To reduce morbidity and mortality associated with overdoses, FDA is:

  • Expanding availability and access to overdose reversal products, including naloxone, by supporting accelerated review of products and exploring over-the-counter access
  • Supporting development of novel overdose reversal products
  • Supporting development and authorization of fentanyl test strips to test human specimens at the point of care

United States Government Partners

  • Department of Health & Human Services (HHS)
  • National Institutes of Health (NIH)
  • Centers for Disease Control and Prevention (CDC)
  • Centers for Medicare & Medicaid Services (CMS)
  • Substance Abuse and Mental Health Services Administration (SAMHSA)
  • Indian Health Service (IHS)

FDA Activities

Back to Top